Questions
Semax FAQ
Direct, cited answers to the questions people actually ask about Semax.
Is Semax a neuroprotective peptide for stroke research?
Yes — it is the most-studied use. Intranasal Semax given for six days in a rat model of focal photoinduced prefrontal-cortex ischemia decreased the volume of cortical infarction and improved retention of a conditioned passive-avoidance response, an antiamnesic effect [4]. Neuroprotection in cerebral ischemia is its registered Russian indication, but no Western randomized trials exist.
What are the neuroprotective properties of the ACTH fragment peptide Semax in ischemia-reperfusion models?
In ischemia-reperfusion models the protective program reproduces at multiple molecular levels: transcriptome analysis confirmed protective gene-expression changes [9], a proteome study confirmed it at the protein level [10], and Semax suppressed pro-inflammatory mediator transcripts after reversible ischemia [11]. The dominant mechanism is an immune-gene and vascular-gene shift rather than a single receptor action [5].
What does Semax do in animal models of neurodegeneration?
In animal injury models Semax is protective. Beyond stroke, a 2025 study found that in mice with spinal-cord injury it improved functional recovery and reduced pyroptosis, acting on the mu-opioid-receptor gene Oprm1 via a USP18 and FTO pathway [7]. The Parkinson's and Alzheimer's evidence is preclinical only; there are no controlled human neurodegeneration trials.
How does Semax compare to Selank for cognitive effects and anxiety?
They are different peptides with different leanings: Semax is neurotrophic and cognition-leaning, raising BDNF protein in rat basal forebrain and binding a specific site there (KD 2.4 nM) [1], while Selank is a tuftsin-based anxiolytic. Both inhibit enkephalin-degrading enzymes in vitro, Semax more potently [3]. See the Semax vs Selank page for the full comparison.
What is Semax?
Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, engineered from the ACTH(4-7) fragment of adrenocorticotropic hormone with a Pro-Gly-Pro tail added to slow its breakdown. It is a neuropeptide studied as a nootropic and neuroprotective agent, and it binds a specific basal-forebrain site that raises BDNF protein [1]. It is a prescription drug in Russia and Ukraine and a research chemical in the US.
What is Semax peptide used for?
In Russia and Ukraine it is an approved drug for ischemic stroke, transient ischemic attack, cognitive impairment, and optic-nerve disease [18]. Elsewhere it is an unapproved research chemical used informally as a nootropic. The research supports neuroprotection in rodent stroke models and neurotrophin (BDNF/NGF) upregulation [4][1]. See what is semax peptide used for for the full reading.
Is Semax a peptide?
Yes. Semax is a peptide — specifically a heptapeptide, a chain of seven amino acids (Met-Glu-His-Phe-Pro-Gly-Pro), with a molecular weight of about 813.9 Da. It is built from the ACTH(4-7) hormone fragment plus a C-terminal Pro-Gly-Pro tripeptide that slows enzymatic degradation [16].
How does Semax work?
Through several overlapping actions, not one receptor. It rapidly raises the neurotrophins BDNF and NGF in a region-specific way [2] and binds a specific basal-forebrain site that increases BDNF protein (KD 2.4 nM) [1]; it inhibits enkephalin-degrading enzymes in human serum (IC50 ~10 microM) [3]; and in stroke models it drives an immune- and vascular-gene shift that underlies its neuroprotection [5].
How does Semax increase BDNF?
Rapidly and region-specifically. A single 50 microg/kg intranasal dose raised BDNF messenger RNA in the rat hippocampus and brainstem within hours [2], and at 50 and 250 microg/kg Semax increased BDNF protein in the basal forebrain three hours after dosing while binding a specific, reversible, calcium-dependent site there with a dissociation constant of 2.4 nM [1].
How does Semax modulate BDNF and NGF expression in research models?
The pattern is gene- and region-specific, not a uniform increase. A single 50 microg/kg dose raised NGF and BDNF messenger RNA in the hippocampus and BDNF in the brainstem and cerebellum, while NGF messenger RNA fell in the frontal cortex [2]. The dynamics also differ over time across hippocampus, frontal cortex, and retina [13], and the Pro-Gly-Pro metabolite independently activates neurotrophin gene transcription [8].
Does Semax help with focus and mood?
Community reports frequently describe quick mental clarity, sustained focus, and a modest mood lift — anecdotal, not clinical evidence, and detailed on the Semax effects page. The mechanistic basis is real (neurotrophin upregulation [1] and enkephalinase inhibition that prolongs endogenous opioid signaling [3]), but a substantial minority report little or no effect, and there are no controlled human cognition trials.
Is Semax effective as a nootropic for cognition?
It is classed as a nootropic in Russian practice, with a plausible mechanism — region-specific BDNF and NGF upregulation that supports learning and memory [1][2] — and rodent evidence that it corrects behavioral deficits [15]. But there are no controlled human cognition trials, and reports range from clear benefit to nothing at all, so its nootropic status rests on mechanism plus anecdote, not proof.
Has anyone found Semax effective for studying or exams?
Some research-use community members report easier focus and faster reading that they find useful for demanding mental work, with gains they say become clearest after several consecutive days — anecdotal reports, not clinical evidence, summarized on the Semax effects page. Others report little effect. No controlled study has tested Semax for academic performance, and this is not a recommendation to use it.
Does Semax have anti-depressive effects?
There is a mechanistic rationale but no Western trial. In human serum in vitro Semax inhibited enkephalin-degrading enzymes (IC50 ~10 microM), which would prolong the body's own opioid-peptide signaling [3], and in rats it corrected long-lasting negative behavioral effects of neonatal isolation [15]. Community mood reports are mixed, with some describing a lift and others feeling flat; no controlled human depression trial supports an antidepressant claim.
Is Semax useful for anxiety?
Semax is studied mainly for neuroprotection and cognition rather than anxiety; the related peptide Selank carries the Russian anxiolytic registration. Semax did correct long-lasting behavioral effects of neonatal isolation in rats [15], and both peptides inhibit enkephalin-degrading enzymes in vitro [3], but no controlled human trial supports using Semax to treat an anxiety disorder.
I fall asleep on Semax - does Semax make you tired?
Most reports describe Semax as clarifying rather than sedating, but a notable minority report a comedown into tiredness or sleepiness as the effect fades, and a few feel drowsy rather than stimulated — anecdotal, not clinical evidence, and covered on the Semax effects page. Some attribute this to late dosing or poor stacking. There is no pharmacological study characterizing a sedative effect; in rats Semax corrected stress-related behavioral deficits [15].
Ashwagandha, L-theanine, or Semax for anxiety - which matters most?
This site only summarizes the Semax literature, so it cannot rank those three. For Semax specifically, the relevant data are an in-vitro enkephalinase inhibition that could influence mood [3] and correction of stress-related behavioral deficits in rats [15]; there is no controlled human anxiety trial. Selank, not Semax, is the peptide with the Russian anxiolytic registration. Nothing here is medical or comparative health advice.
What effects does Semax have on dopamine and serotonin pathways?
More nuanced than often stated. In mice, 0.15 mg/kg raised the striatal serotonin metabolite 5-HIAA (tissue +25% at 2 hours) and markedly potentiated amphetamine-evoked dopamine release and locomotion — but it did not by itself change baseline dopamine [20]. So claims that Semax directly raises dopamine overstate the evidence; it modulates and potentiates these systems rather than flooding them.
Is Semax a stimulant?
No. Semax is classed as a nootropic, not a stimulant. In mice it raised the serotonin metabolite 5-HIAA and potentiated amphetamine-evoked dopamine release but did not by itself raise baseline dopamine [20]. Users commonly describe "focus without the jitters" rather than a stimulant rush, though a substantial minority report feeling little at all.
What is the difference between Semax and Selank?
They are distinct peptides and must not be conflated. Semax is a synthetic ACTH(4-7) heptapeptide that is neurotrophic and neuroprotective — raising BDNF and reducing stroke damage in rodents [1][4]. Selank is a tuftsin-based heptapeptide studied mainly as an anxiolytic. They share a Russian origin and both inhibit enkephalin-degrading enzymes in vitro, Semax more potently [3]. See Semax vs Selank.
Can Semax be useful for Parkinson's disease neuroprotection?
The neuroprotection evidence is real but preclinical. Semax is protective in rodent injury models — reducing infarct volume in stroke [4] and improving recovery after spinal-cord injury via an Oprm1/USP18/FTO pathway [7] — but the Parkinson's-specific evidence is limited to animal models, and there are no controlled human Parkinson's trials. It is not an approved or proven treatment for the disease.
Does Semax affect dopaminergic neurons in Parkinson's models?
Semax modulates dopaminergic signaling — in mice it potentiated amphetamine-evoked dopamine release without raising baseline dopamine on its own [20] — but the published Parkinson's-model evidence on dopaminergic neurons specifically is preclinical and limited. The broader neuroprotective program (immune- and vascular-gene modulation, infarct reduction) is best characterized in cerebral-ischemia models [5][4]. No controlled human Parkinson's data exist.